Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Mr. John McAdoryCOO | 145,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,06 | 645,00k | 29,00% |
| 2026-06-01 | Mr. Stephen C. GloverIndependent Director | 96,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,06 | 96,00k | - |
| 2026-03-12 | Mr. Jared KellyCEO & Director | 5,05k | 4,85k | Acquisto | 0,96 | 114,05k | 4,63% |
| 2026-03-11 | Mr. James T. ParsonsIndependent Director | 10,00k | 10,30k | Acquisto | 1,03 | 41,85k | 31,40% |
| 2026-02-11 | Mr. Jared KellyCEO & Director | 35,10k | 29,52k | Acquisto | 0,84 | 109,00k | 47,50% |
| 2026-02-12 | Mr. Kirk J. LookCFO | 12,00k | 10,10k | Acquisto | 0,84 | 287,52k | 4,36% |
| 2026-02-12 | Ms. Patricia S. AndrewsIndependent Director | 35,40k | 30,29k | Acquisto | 0,86 | 78,13k | 82,85% |
| 2026-02-11 | Mr. Andrew P. AromandoChief Business Officer | 29,60k | 25,42k | Acquisto | 0,86 | 55,10k | 116,08% |
| 2026-02-12 | Ms. Deborah M. BrownIndependent Director | 25,00k | 21,24k | Acquisto | 0,85 | 109,85k | 29,46% |
| 2026-02-12 | Ms. Allison HagermanCTO | 10,00k | 8,30k | Acquisto | 0,83 | 115,06k | 9,52% |
| 2026-02-12 | Dr. Thomas C. HeinemanChief Medical Officer | 12,13k | 10,03k | Acquisto | 0,83 | 282,82k | 4,48% |
| 2026-02-12 | Mr. Wayne F. PisanoChairman of the Board | 30,00k | 25,34k | Acquisto | 0,84 | 492,41k | 6,49% |
| 2026-02-11 | Prof. Bernd Robert SeizingerIndependent Director | 100,00k | 83,45k | Acquisto | 0,83 - 0,85 | 566,99k | 21,41% |
| 2026-01-16 | Prof. Bernd Robert SeizingerIndependent Director | 100,00k | 103,77k | Acquisto | 1,04 | 466,99k | 27,25% |
| 2025-12-15 | Mr. Andrew P. AromandoChief Business Officer | 250,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,99 | 1,30M | 23,81% |
| 2025-12-15 | Mr. Kirk J. LookCFO | 250,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,99 | 1,67M | 17,64% |
| 2025-12-15 | Ms. Allison HagermanCTO | 250,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,99 | 792,99k | 46,04% |
| 2025-12-15 | Dr. Thomas C. HeinemanChief Medical Officer | 250,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,99 | 1,58M | 18,74% |
| 2025-12-15 | Mr. Jared KellyCEO & Director | 350,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,99 | 5,55M | 6,73% |
| 2025-12-10 | Mr. Kirk J. LookCFO | -55,00k | 0,00 | Other Derivative Disposition | - | 1,42M | -3,74% |
| 2025-12-10 | Ms. Allison HagermanCTO | -55,00k | 0,00 | Other Derivative Disposition | - | 542,99k | -9,20% |
| 2025-12-10 | Dr. Thomas C. HeinemanChief Medical Officer | -55,00k | 0,00 | Other Derivative Disposition | - | 1,33M | -3,96% |
| 2025-12-10 | Amy LevinInsider | -25,00k | 0,00 | Other Derivative Disposition | - | 313,18k | -7,39% |
| 2025-12-09 | Ms. Allison HagermanCTO | -5,26k | 0,00 | Other Derivative Disposition | - | 597,99k | -0,87% |
| 2025-12-01 | Mr. Kirk J. LookCFO | -48,84k | 0,00 | Other Derivative Disposition | - | 1,47M | -3,21% |
| 2025-09-01 | Amy LevinInsider | -50,00k | 0,00 | Other Derivative Disposition | - | 338,18k | -12,88% |
| 2025-08-18 | Prof. Bernd Robert SeizingerIndependent Director | 150,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,08 | 270,00k | 125,00% |
| 2025-08-18 | Mr. James T. ParsonsIndependent Director | 150,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,08 | 255,00k | 142,86% |
| 2025-08-18 | Mr. Andrew P. AromandoChief Business Officer | 300,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,08 | 1,05M | 40,00% |
| 2025-08-18 | Mr. Jonathan M. N. RigbyIndependent Director | 150,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,08 | 255,00k | 142,86% |
| 2025-08-18 | Mr. Wayne F. PisanoChairman of the Board | 157,50k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,08 | 307,50k | 105,00% |
| 2025-08-18 | Ms. Patricia S. AndrewsIndependent Director | 150,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,08 | 195,00k | 333,33% |
| 2025-08-18 | Ms. Angela Frances HolthamIndependent Director | 150,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,08 | 270,00k | 125,00% |
| 2025-08-18 | Mr. Kirk J. LookCFO | 570,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,08 | 1,52M | 59,95% |
| 2025-08-18 | Ms. Deborah M. BrownIndependent Director | 150,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,08 | 275,26k | 119,75% |
| 2025-08-18 | Ms. Allison HagermanCTO | 240,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,08 | 603,26k | 66,07% |
| 2025-08-18 | Dr. Thomas C. HeinemanChief Medical Officer | 570,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,08 | 1,46M | 64,10% |
| 2025-08-22 | Dr. Thomas C. HeinemanChief Medical Officer | -70,00k | 0,00 | Other Derivative Disposition | - | 1,39M | -4,80% |
| 2025-08-18 | Amy LevinInsider | 150,98k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,08 | 388,18k | 63,65% |
| 2025-08-18 | Mr. Jared KellyCEO & Director | 450,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,08 | 5,20M | 9,47% |
| 2025-08-18 | Ms. Allison HagermanCTO | 1,97k | 0,00 | Derivative Exercise and Retained Stock | - | 69,84k | 2,90% |
| 2025-08-18 | Mr. Kirk J. LookCFO | 9,40k | 0,00 | Derivative Exercise and Retained Stock | - | 159,47k | 6,26% |
| 2025-08-18 | Dr. Thomas C. HeinemanChief Medical Officer | 7,97k | 0,00 | Derivative Exercise and Retained Stock | - | 156,07k | 5,38% |
| 2025-08-18 | Amy LevinInsider | 1,97k | 0,00 | Derivative Exercise and Retained Stock | - | 38,25k | 5,42% |
| 2025-08-12 | Mr. Jared KellyCEO & Director | 23,50k | 20,28k | Acquisto | 0,86 | 73,90k | 46,63% |
| 2025-07-23 | Mr. Jonathan M. N. RigbyIndependent Director | 42,73k | 0,00 | Derivative Exercise and Retained Stock | - | 42,73k | - |
| 2025-07-17 | Ms. Allison HagermanCTO | 4,60k | 5,72k | Acquisto | 1,24 | 67,88k | 7,27% |
| 2025-07-17 | Dr. Thomas C. HeinemanChief Medical Officer | 15,00k | 19,05k | Acquisto | 1,27 | 148,10k | 11,27% |
| 2025-07-15 | Mr. Andrew P. AromandoChief Business Officer | 25,50k | 30,24k | Acquisto | 1,19 | 25,50k | - |
| 2025-07-15 | Mr. Kirk J. LookCFO | 12,80k | 14,98k | Acquisto | 1,17 | 150,07k | 9,33% |
| 2025-07-16 | Mr. Jared KellyCEO & Director | 50,40k | 60,06k | Acquisto | 1,19 | 50,40k | - |
| 2025-07-16 | Prof. Bernd Robert SeizingerIndependent Director | 26,34k | 0,00 | Derivative Exercise and Retained Stock | - | 366,99k | 7,73% |
| 2025-07-16 | Mr. James T. ParsonsIndependent Director | 23,75k | 0,00 | Derivative Exercise and Retained Stock | - | 31,85k | 293,05% |
| 2025-07-16 | Mr. Wayne F. PisanoChairman of the Board | 34,54k | 0,00 | Derivative Exercise and Retained Stock | - | 258,31k | 15,44% |
| 2025-07-16 | Ms. Patricia S. AndrewsIndependent Director | 21,59k | 0,00 | Derivative Exercise and Retained Stock | - | 42,73k | 102,11% |
| 2025-07-16 | Ms. Angela Frances HolthamIndependent Director | 28,50k | 0,00 | Derivative Exercise and Retained Stock | - | 183,64k | 18,37% |
| 2025-07-16 | Ms. Deborah M. BrownIndependent Director | 26,77k | 0,00 | Derivative Exercise and Retained Stock | - | 84,85k | 46,09% |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
